Skip to main content

BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW), Jupiter Wellness Acquisition Corp. Schedule Special Meeting for Approval of Proposed Business Combination

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair, skin, and sexual wellness, is reporting that the U.S. Securities and Exchange Commission (“SEC”) has declared effective its registration statement. Jupiter Wellness, the business combination sponsor, observed that the registration statement was regarding Chijet Motor Company Inc., a developer of next-generation electric vehicles, in connection with a previously announced proposed business combination with Jupiter Wellness Acquisition Corp. (NASDAQ: JWAC), a special purpose acquisition company. A special meeting of Jupiter Wellness Acquisition Corp. shareholders has been scheduled for April 20, 2023, to approve the proposed combination; the business combination is expected to close shortly after the special meeting, pending shareholder approval and other customary closing conditions. Chijet primary business is currently the development, manufacture, sales and services of traditional fuel and electric vehicles. Following the business combination, its China-based factory will be dedicated to EV production; the company’s headquarters will be also located at the planned Yantai factory.

To view the full press release, visit https://ibn.fm/oCJb6

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.